Adult-onset Still disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:829M06.1
Who is this for?
Show terms as
1FDA treatments6Active trials27Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Adult-onset Still disease (AOSD) is a rare inflammatory disorder that affects the whole body. It is sometimes called Adult Still disease and is considered the adult form of a childhood condition known as systemic juvenile idiopathic arthritis. The disease causes episodes of high spiking fevers (often 102°F or higher), a salmon-pink skin rash that comes and goes, and painful, swollen joints. These flare-ups can last for weeks or months. The inflammation can also affect internal organs, including the liver, spleen, lymph nodes, heart, and lungs. In some people, the disease follows a single episode and then goes away, while in others it becomes chronic and leads to long-term joint damage. The exact cause of AOSD is not fully understood. It is thought to involve an overactive immune system, where the body's defense mechanisms mistakenly attack its own tissues. Certain immune signaling molecules, especially interleukin-1 (IL-1), interleukin-6 (IL-6), and interleukin-18 (IL-18), are found at very high levels during flares. A serious and potentially life-threatening complication called macrophage activation syndrome (MAS) can occur, where the immune system becomes dangerously overactive. Treatment focuses on controlling inflammation and preventing organ damage. Nonsteroidal anti-inflammatory drugs (NSAIDs) may help mild cases, but most patients need corticosteroids like prednisone. For patients who do not respond well or who need to reduce steroid use, biologic medications that block specific immune signals — such as anakinra, canakinumab, and tocilizumab — have become important treatment options. With proper treatment, many people with AOSD can achieve good disease control and maintain a good quality of life.

Also known as:

Key symptoms:

High spiking fevers, often occurring once or twice dailySalmon-pink skin rash that appears with fever and fades when fever dropsJoint pain and swelling, especially in the knees, wrists, and anklesSevere sore throatSwollen lymph nodesEnlarged liver or spleenMuscle pain and body achesExtreme fatigue and feeling unwellWeight lossChest pain from inflammation around the heart or lungsAbdominal painVery high white blood cell countElevated ferritin levels in the bloodJoint stiffness, especially in the morning

Clinical phenotype terms (50)— hover any for plain English
Arthralgia/arthritisHP:0005059Increased total neutrophil countHP:0011897PleuritisHP:0002102
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

8 events
Nov 2025A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease

Novartis Pharmaceuticals — PHASE2

TrialRECRUITING
Sep 2025A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease

Ruijin Hospital

TrialNOT YET RECRUITING
Aug 2025Therapeutic Value of Sirolimus in Refractory Adult-Onset Still's Disease

Ruijin Hospital — NA

TrialACTIVE NOT RECRUITING
Aug 2022A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)

Swedish Orphan Biovitrum — PHASE3

TrialACTIVE NOT RECRUITING
Aug 2020Rheumatology Patient Registry and Biorepository

Yale University

TrialRECRUITING
May 2018Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

TrialRECRUITING
Jul 2017Acostill ( RaDiCo Cohort) (RaDiCo Acostill)

Institut National de la Santé Et de la Recherche Médicale, France

TrialRECRUITING
May 2014Glycosylated Ferritin in Macrophagic Activation Syndromes

Brugmann University Hospital

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

ILARIS

canakinumab· Novartis Pharmaceuticals Corporation

indicated for the treatment of active Still's Disease, including Adult-Onset Still's Disease (AOSD) and Systemic Juvenile Idiopathic Arthritis (SJIA) in patients 2 years of age and older

Clinical Trials

6 recruitingView all trials with filters →
Phase 31 trial
A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)
Phase 3
Active Prior treatment eligible
PI: Masaaki Mori, MD (St. Marianna University Hospital) · Sites: Fukushima, Fukushima; Kobe, Hyōgo +6 more · Age: 899 yrs
Phase 21 trial
A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease
Phase 2
Actively Recruiting
· Sites: Cincinnati, Ohio; Portland, Oregon +20 more · Age: 1100 yrs
Other4 trials
Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions
Actively Recruiting
PI: Michael J Ombrello, M.D. (National Institute of Arthritis and Musculoskeleta) · Sites: Bethesda, Maryland · Age: 0100 yrs
Acostill ( RaDiCo Cohort) (RaDiCo Acostill)
Actively Recruiting
PI: Sophie Georgin-Lavialle, PHD (INSERM U933) · Sites: Paris, Île-de-France Region
Rheumatology Patient Registry and Biorepository
Actively Recruiting
PI: Monique Hinchcliff, MD (Yale University) · Sites: New Haven, Connecticut · Age: 1899 yrs
Glycosylated Ferritin in Macrophagic Activation Syndromes
Actively Recruiting
· Sites: Brussels · Age: 085 yrs

Specialists

Showing 25 of 27View all specialists →
SP
Sophie Georgin-Lavialle, PHD
Specialist
PI on 1 active trial
MM
Michael J Ombrello, M.D.
SAINT LOUIS, MO
Specialist
PI on 1 active trial
MS
Mikhail Samsonov
Specialist
PI on 17 active trials
MM
Masaaki Mori, MD
Fukushima, Fukushima
Specialist

Rare Disease Specialist

PI on 2 active trials
QL
Qianjin Lu
Specialist
PI on 5 active trials110 Adult-onset Still disease publications
MM
Monique Hinchcliff, MD
NORTH HAVEN, CT
Specialist
PI on 2 active trials
NS
Nicholas Farinola, B.Sc (Biomed. Sci.),BMBS,FRACP
Specialist
PI on 2 active trials
UM
Uwe Ullman, MD
Specialist
PI on 1 active trial
DP
Dan C Nordstrom, MD, PhD
MADISON, WI
Specialist
PI on 1 active trial
CP
Cem Gabay, Prof.
Specialist
PI on 1 active trial
HG
Henrique A Mayrink Giardini
MD
Specialist
2 Adult-onset Still disease publications
IA
Isabele Parente de Brito Antonelli
MD
Specialist
2 Adult-onset Still disease publications
GL
Giuseppe Lopalco
MD
Specialist
2 Adult-onset Still disease publications
IP
Ilenia Pantano
Specialist
2 Adult-onset Still disease publications
PS
Petros P Sfikakis
MD
Specialist
2 Adult-onset Still disease publications
MT
Maria Tektonidou
MD
Specialist
2 Adult-onset Still disease publications
KL
Katerina Laskari
Specialist
2 Adult-onset Still disease publications
PC
Paola Cipriani
Specialist
2 Adult-onset Still disease publications
SO
Sven Ohlman
Specialist
PI on 1 active trial
PR
Piero Ruscitti
MD
Specialist
4 Adult-onset Still disease publications
FC
Francesco Ciccia
MD
Specialist
3 Adult-onset Still disease publications
DI
Daniela Iacono
MD
Specialist
3 Adult-onset Still disease publications
RG
Roberto Giacomelli
MD
Specialist
3 Adult-onset Still disease publications
AV
Antonio Vitale
MD
Specialist
2 Adult-onset Still disease publications
VC
Valeria Caggiano
MD
Specialist
2 Adult-onset Still disease publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Adult-onset Still disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Adult-onset Still diseaseForum →

No community posts yet. Be the first to share your experience with Adult-onset Still disease.

Start the conversation →

Latest news about Adult-onset Still disease

Disease timeline:

New recruiting trial: Glycosylated Ferritin in Macrophagic Activation Syndromes

A new clinical trial is recruiting patients for Adult-onset Still disease

New recruiting trial: Rheumatology Patient Registry and Biorepository

A new clinical trial is recruiting patients for Adult-onset Still disease

New recruiting trial: A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease

A new clinical trial is recruiting patients for Adult-onset Still disease

New recruiting trial: Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions

A new clinical trial is recruiting patients for Adult-onset Still disease

New recruiting trial: Acostill ( RaDiCo Cohort) (RaDiCo Acostill)

A new clinical trial is recruiting patients for Adult-onset Still disease

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What type of Adult-onset Still disease do I have — is it likely to be a single episode, recurring, or chronic?,What are the signs of macrophage activation syndrome, and what should I do if I suspect it?,Which medications do you recommend, and what are the short-term and long-term side effects?,How often will I need blood tests and follow-up appointments?,Are there biologic therapies that might help me reduce or stop corticosteroids?,What lifestyle changes can help me manage fatigue and joint symptoms?,Should I see any other specialists, and are there clinical trials I might be eligible for?

Common questions about Adult-onset Still disease

What is Adult-onset Still disease?

Adult-onset Still disease (AOSD) is a rare inflammatory disorder that affects the whole body. It is sometimes called Adult Still disease and is considered the adult form of a childhood condition known as systemic juvenile idiopathic arthritis. The disease causes episodes of high spiking fevers (often 102°F or higher), a salmon-pink skin rash that comes and goes, and painful, swollen joints. These flare-ups can last for weeks or months. The inflammation can also affect internal organs, including the liver, spleen, lymph nodes, heart, and lungs. In some people, the disease follows a single episo

How is Adult-onset Still disease inherited?

Adult-onset Still disease follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Adult-onset Still disease typically begin?

Typical onset of Adult-onset Still disease is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Adult-onset Still disease?

Yes — 6 recruiting clinical trials are currently listed for Adult-onset Still disease on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Adult-onset Still disease?

25 specialists and care centers treating Adult-onset Still disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.